Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
137.75
+8.65 (6.70%)
At close: Feb 21, 2025, 4:00 PM
138.95
+1.20 (0.87%)
After-hours: Feb 21, 2025, 6:21 PM EST
Axsome Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6,717 | 4,100 | 3,766 | 3,349 | 1,424 | 3,042 | |
| Market Cap Growth | 8.87% | 8.87% | 12.44% | 135.22% | -53.20% | -20.03% | |
| Enterprise Value | 6,595 | 3,965 | 3,535 | 3,216 | 1,359 | 2,888 | |
| Last Close Price | 137.75 | 84.61 | 79.59 | 77.13 | 37.78 | 81.47 | |
| PS Ratio | 17.11 | 10.63 | 13.92 | 66.94 | - | - | |
| PB Ratio | 117.58 | 71.92 | 19.72 | 30.57 | 91.10 | 26.74 | |
| P/TBV Ratio | - | - | 29.97 | 84.61 | 91.10 | 26.74 | |
| EV/Sales Ratio | 17.10 | 10.28 | 13.06 | 64.28 | - | - | |
| Debt / Equity Ratio | 3.38 | 3.38 | 0.98 | 0.86 | 3.18 | 0.44 | |
| Asset Turnover | 0.67 | 0.67 | 0.59 | 0.24 | - | - | |
| Inventory Turnover | 2.16 | 2.16 | 2.68 | - | - | - | |
| Quick Ratio | 1.99 | 1.99 | 3.46 | 2.47 | 3.75 | 7.85 | |
| Current Ratio | 2.11 | 2.11 | 3.63 | 2.54 | 3.75 | 7.85 | |
| Return on Equity (ROE) | -231.63% | -231.63% | -159.21% | -298.97% | -201.51% | -70.36% | |
| Return on Assets (ROA) | -27.28% | -27.28% | -24.86% | -52.29% | -56.91% | -30.46% | |
| Return on Capital (ROIC) | -50.30% | -50.30% | -39.31% | -81.33% | -68.00% | -34.16% | |
| Earnings Yield | -4.28% | -7.00% | -6.35% | -5.59% | -9.16% | -3.38% | |
| FCF Yield | -1.92% | -3.14% | -3.87% | -3.50% | -7.62% | -2.58% | |
| Buyback Yield / Dilution | -5.48% | -5.48% | -11.73% | -8.07% | -1.11% | -9.37% | |
| Total Shareholder Return | -5.48% | -5.48% | -11.73% | -8.07% | -1.11% | -9.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.